Slide 1New regulatory requirements for first into man studies in France Dominique Tremblay External Expert at the French Medical Agency Agence Française de Sécutrité Sanitaire…

Slide 1 1 Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008 Workshop Minimizing risk by optimizing clinical trial design and performance Wolfgang…

Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008 Workshop Minimizing risk by optimizing clinical trial design and performance Wolfgang Timmer,…

John Posner Human Pharmacology Training Programmes â UK Diploma and Certificate in Human Pharmacology Faculty of Pharmaceutical Medicine John Posner Director of D/CHP Programmes…

Relevance of pre-clinical findings for the interpretation of Adverse Events Tim Mant, BSc, FRCP, FFPM Senior Medical Advisor - GDRU, Quintiles Limited Visiting Professor…

Clinical Trial Authorisation in Germany for First-in-Man Trials with NCEs Thomas Sudhop, MD Presented by Christian Steffen, MD Federal Institute for Drugs and Medical Devices…

Minimizing risk by optimizing clinical trial design AGAH Workshop 19 April 2008 Workshop Minimizing risk by optimizing clinical trial design and performance Wolfgang Timmer,…